Trial NCT03779100

View at ClinicalTrials.gov 
Org. Study IDs: HCC-S075

Last trial update was posted on 2019-01-28

MeSH Interventions

Antibodies Immunoglobulins Lenvatinib

MeSH Conditions

Cholangiocarcinoma

Other Conditions

Intrahepatic Cholangiocarcinoma

Stopping Reasons

Protocol modification

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID